This article has been updated to clarify that Qiagen's joint venture PreAnalytix received the FDA clearance, and not Qiagen.

NEW YORK (GenomeWeb News) – PreAnalytix, a joint venture of Qiagen and Becton Dickinson, has received US Food and Drug Administration clearance for the automation of the PAXgene Blood RNA System on Qiagen's QIAcube platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.